Ligand profile
CHEMBL453805
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_05433 — Enoyl-[acyl-carrier-protein] reductase [NADH]
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL453805- UniProt (similar protein)
P0AEK4- Target protein
- KP13_05433
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 52.6
- −1 ≤ LogP ≤ 5 3.88
- MW ≤ 500 Da 270.3
- LogP ≤ 5 3.88
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 52.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(C)=CCOc1c2occc2cc2ccc(=O)oc12CC(C)=CCOc1c2occc2cc2ccc(=O)oc12
InChI=1S/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H3InChI=1S/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H3
OLOOJGVNMBJLLR-UHFFFAOYSA-NOLOOJGVNMBJLLR-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Activity
- Active
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL453805 →
- UniProt UniProt P0AEK4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL453805”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05433.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 59
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).